Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
0.9700
Dollar change
-0.0129
Percentage change
-1.31
%
Index- P/E- EPS (ttm)-1.21 Insider Own35.02% Shs Outstand25.03M Perf Week-7.62%
Market Cap24.32M Forward P/E- EPS next Y-1.04 Insider Trans0.00% Shs Float16.29M Perf Month-11.01%
Income-34.10M PEG- EPS next Q-0.27 Inst Own11.02% Short Float0.96% Perf Quarter22.46%
Sales0.00M P/S- EPS this Y19.37% Inst Trans-0.13% Short Ratio2.25 Perf Half Y43.07%
Book/sh2.59 P/B0.37 EPS next Y-5.23% ROA-35.38% Short Interest0.16M Perf Year-44.25%
Cash/sh2.62 P/C0.37 EPS next 5Y- ROE-40.52% 52W Range0.51 - 1.93 Perf YTD40.17%
Dividend Est.- P/FCF- EPS past 5Y-16.26% ROI-49.66% 52W High-49.64% Beta0.16
Dividend TTM- Quick Ratio11.92 Sales past 5Y0.00% Gross Margin- 52W Low90.20% ATR (14)0.09
Dividend Ex-Date- Current Ratio11.92 EPS Y/Y TTM23.36% Oper. Margin0.00% RSI (14)44.96 Volatility7.84% 9.67%
Employees27 Debt/Eq0.10 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price4.67
Option/ShortNo / Yes LT Debt/Eq0.06 EPS Q/Q25.56% Payout- Rel Volume0.34 Prev Close0.98
Sales Surprise- EPS Surprise2.47% Sales Q/Q- EarningsFeb 28 BMO Avg Volume69.28K Price0.97
SMA20-7.36% SMA502.40% SMA20010.00% Trades Volume23,775 Change-1.31%
Date Action Analyst Rating Change Price Target Change
Jul-01-21Downgrade Berenberg Buy → Hold $12
Jun-29-21Downgrade Oppenheimer Outperform → Perform $30 → $14
Mar-01-21Initiated Piper Sandler Overweight $25
Mar-01-21Initiated Oppenheimer Outperform $36
Mar-01-21Initiated Citigroup Buy $30
Mar-01-21Initiated Berenberg Buy $27
Apr-09-24 07:30AM
Apr-04-24 04:05PM
Mar-22-24 07:30AM
Mar-06-24 07:30AM
Feb-28-24 07:30AM
07:30AM Loading…
Feb-07-24 07:30AM
Jan-04-24 07:30AM
Nov-07-23 08:09AM
07:30AM
Nov-03-23 04:05PM
Nov-01-23 07:30AM
Oct-25-23 09:05AM
Oct-23-23 07:30AM
Sep-27-23 07:30AM
Sep-21-23 07:30AM
07:30AM Loading…
Sep-13-23 07:30AM
Aug-30-23 07:30AM
Aug-19-23 10:44AM
Aug-03-23 07:30AM
Aug-02-23 07:30AM
Jun-13-23 07:30AM
Jun-01-23 07:30AM
May-31-23 07:30AM
May-09-23 07:30AM
Apr-20-23 07:30AM
Apr-18-23 04:05PM
Apr-13-23 07:30AM
Mar-30-23 07:30AM
Mar-28-23 07:30AM
Mar-23-23 11:56AM
07:30AM Loading…
Mar-21-23 07:30AM
Mar-14-23 04:35PM
Mar-07-23 05:15PM
Mar-06-23 07:30AM
Feb-21-23 07:30AM
Feb-16-23 07:30AM
Feb-14-23 07:30AM
Feb-06-23 07:30AM
Jan-05-23 07:30AM
Dec-08-22 01:10PM
10:40AM
07:30AM
Nov-22-22 07:30AM
Nov-21-22 07:30AM
06:00AM
Nov-10-22 09:00AM
Nov-08-22 07:30AM
Nov-07-22 07:30AM
Nov-02-22 07:30AM
Oct-14-22 10:22AM
Oct-05-22 08:05AM
Sep-30-22 04:05PM
Sep-21-22 04:05PM
Aug-31-22 07:30AM
Aug-23-22 07:30AM
Aug-11-22 07:02AM
Aug-09-22 07:30AM
Jun-01-22 07:30AM
May-25-22 07:30AM
May-10-22 07:30AM
May-07-22 09:40AM
Apr-21-22 09:09AM
Mar-10-22 07:30AM
Mar-09-22 04:05PM
Mar-03-22 07:30AM
Feb-11-22 07:30AM
Jan-17-22 11:22AM
Jan-06-22 08:00AM
Dec-16-21 09:01AM
Dec-13-21 04:01PM
Nov-19-21 04:02PM
Nov-17-21 10:37AM
Nov-12-21 07:02AM
Nov-09-21 08:54AM
Nov-03-21 09:01AM
Oct-01-21 08:05AM
Aug-17-21 01:56PM
Aug-09-21 12:00PM
Aug-04-21 07:45AM
Aug-02-21 08:01AM
Jun-29-21 01:49PM
Jun-28-21 04:05PM
May-19-21 05:03PM
May-12-21 07:41AM
May-05-21 08:05AM
May-04-21 07:18AM
Apr-05-21 08:00AM
Mar-25-21 08:00AM
Mar-22-21 08:00AM
Mar-09-21 08:30AM
Mar-05-21 03:30PM
Feb-10-21 04:55PM
Feb-09-21 11:08AM
Feb-05-21 05:26PM
Feb-04-21 05:56PM
Feb-03-21 08:44PM
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Celebi JohnPresident and CEOSep 11 '23Buy0.85500425111,311Sep 13 08:43 AM
Apeiron Investment Group Ltd.10% OwnerJun 01 '23Sale1.583,441,6615,437,8240Jun 02 05:03 PM